Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer
Management of metastatic or advanced prostate cancer has acquired several therapeutic approaches that have drastically changed the course of the disease. In particular due to the high sensitivity of prostate cancer cells to hormone depletion, several agents able to inhibit hormone production or binding to nuclear receptor have been evaluated and adopted in clinical practice. However, despite several hormonal treatments being available nowadays for the management of advanced or metastatic prostate cancer, the natural history of the disease leads inexorably to the development of resistance to hormone inhibition. Findings regarding the mechanisms that drive this process are of particular and increasing interest as these are potentially related to the identification of new targetable pathways and to the development of new drugs able to improve our patients’ clinical outcomes.
Топ-30
Журналы
|
1
2
3
4
|
|
|
Cancers
4 публикации, 10%
|
|
|
Cells
3 публикации, 7.5%
|
|
|
International Journal of Molecular Sciences
2 публикации, 5%
|
|
|
Expert Review of Anticancer Therapy
2 публикации, 5%
|
|
|
Viruses
1 публикация, 2.5%
|
|
|
Biomedicines
1 публикация, 2.5%
|
|
|
Frontiers in Bioengineering and Biotechnology
1 публикация, 2.5%
|
|
|
Frontiers in Immunology
1 публикация, 2.5%
|
|
|
Frontiers in Endocrinology
1 публикация, 2.5%
|
|
|
Molecular Cancer
1 публикация, 2.5%
|
|
|
Chemical Engineering Journal
1 публикация, 2.5%
|
|
|
Journal of Molecular Graphics and Modelling
1 публикация, 2.5%
|
|
|
Actas Urológicas Españolas (English Edition)
1 публикация, 2.5%
|
|
|
Actas Urologicas Espanolas
1 публикация, 2.5%
|
|
|
Annals of Oncology
1 публикация, 2.5%
|
|
|
Molecular Aspects of Medicine
1 публикация, 2.5%
|
|
|
International Journal of Cancer
1 публикация, 2.5%
|
|
|
IUBMB Life
1 публикация, 2.5%
|
|
|
ACS Applied Bio Materials
1 публикация, 2.5%
|
|
|
Expert Review of Molecular Diagnostics
1 публикация, 2.5%
|
|
|
BioMed Research International
1 публикация, 2.5%
|
|
|
Molecular Cancer Research
1 публикация, 2.5%
|
|
|
Translational Andrology and Urology
1 публикация, 2.5%
|
|
|
Translational Cancer Research
1 публикация, 2.5%
|
|
|
Annals of Translational Medicine
1 публикация, 2.5%
|
|
|
Asian Journal of Andrology
1 публикация, 2.5%
|
|
|
Pathology Research and Practice
1 публикация, 2.5%
|
|
|
Current Oncology Reports
1 публикация, 2.5%
|
|
|
Cell Death and Disease
1 публикация, 2.5%
|
|
|
1
2
3
4
|
Издатели
|
2
4
6
8
10
12
|
|
|
MDPI
11 публикаций, 27.5%
|
|
|
Elsevier
7 публикаций, 17.5%
|
|
|
Springer Nature
4 публикации, 10%
|
|
|
Frontiers Media S.A.
3 публикации, 7.5%
|
|
|
Taylor & Francis
3 публикации, 7.5%
|
|
|
AME Publishing Company
3 публикации, 7.5%
|
|
|
Wiley
2 публикации, 5%
|
|
|
American Chemical Society (ACS)
2 публикации, 5%
|
|
|
Cold Spring Harbor Laboratory
1 публикация, 2.5%
|
|
|
Hindawi Limited
1 публикация, 2.5%
|
|
|
American Association for Cancer Research (AACR)
1 публикация, 2.5%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 2.5%
|
|
|
2
4
6
8
10
12
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.